Immunosuppressive Activity of Cloned Natural Killer (NK1.1+) T Cells Established from Murine Tumor-Infiltrating Lymphocytes

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 4846-4854

  Tamada, Koji ^a   Harada, Mamoru ^a   Abe, Koichiro ^a   Li, Tieli ^a   Tada, Hitoshi ^a   Onoe, Yasuhiro ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CELL CLONE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EXPERIMENTAL MELANOMA; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPHENOTYPING; MOUSE; NATURAL KILLER CELL; PHYSIOLOGY; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031570027     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. + cells. J. Immunol. 145:3209.
2. + subset. J. Immunol. 145:1039.
3. - single-positive thymocyte subpopulation that expresses a highly skewed T cell antigen receptor family. Proc. Natl. Acad. Sci. USA 89:6506.
4. + cells in the liver of mice. J. Exp. Med. 180:699.
5. + T cells in various immune organs. J. Immunol. 155:2972.
6. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
7. Yankelevich, B., C. Knobloch, M. Nowicki, and G. Dennert. 1989. A novel cell type responsible for marrow graft rejection in mice: T cells with NK phenotype cause acute rejection of marrow grafts. J. Immunol. 142:3423.
8. + thymocytes selected by MHC class I molecules. Science 263:1774.
9. - T cells in mice and humans. J. Exp. Med. 180:1097.
10. + T cell populations. Int. Immunol. 7:1157.
11. + thymocyte population associated with intact Fas antigen expression on the target. J. Exp. Med. 180:423.
12. Kikly, K., and G. Dennert. 1992. Evidence for a role for T cell receptors (TCR) in the effector phase of acute bone marrow graft rejection. J. Immunol. 149:1489.
13. Takeda, K., and G. Dennert. 1993. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation. B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med. 177:155.
14. Sumida, T., A. Sakamoto, H. Murata, Y. Makino, H. Takahashi, S. Yoshida, K. Nishioka, I. Iwamoto, and M. Taniguchi. 1995. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1163.
15. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035.
16. Koseki, H., K. Inai, T. Ichikawa, I. Hayata, and M. Taniguchi. 1989. Predominant use of a particular α-chain in suppressor T cell hybridomas specific for keyhole limpet hemocyanin. Int. Immunol. 1:557.
17. Barbo, J. V., J. K. McCormack, J. W. Moorhead, and R. J. Fairchild. 1995. Reconstitution of TCR α-chain expression in deletion mutants restores dinitrophenyl-specific/class I MHC-restricted suppressor molecule production. J. Immunol. 154:1551.
18. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolylic T lymphocytes on a human melanoma. Science 254:164.
19. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gent codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489.
20. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180: 347.
21. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, K. Sakaguchi, E. Appella, J. R. Yannelli, G. J. Adema, T. Miki, and S. A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad Sci. USA 91:6458.
22. Baskar, S., S. Ostrand-Rosenberg, N. Nabavi, L. M. Nadler, G. J. Freeman, and L. H. Glimcher. 1993. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90:5687.
23. Monaco, J. J., S. Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC: possible implication for antigen processing. Science 250:1723.
24. Powis, S. J., E. V. Deverson, W. J. Coadwell, A. Cirucla, N. S. Huskisson, H. Smith, G. W. Butcher, and J. C. Howard. 1992. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class 1 molecule. Nature 357:211.
25. Chen, L., P. S. Linsley, and K. E. Hellstrom. 1993. Cosimulation of T cells for tumor immunity. Immunol. Today 14:483.
26. 2: evidence for secretion of both high and low molecular weight biologically active forms. J. Neuroimmunol. 34:33.
27. Chang, H. L., N. Gillett, I. Figari, A. R. Lopez, M. A. Palladino, and R. Derynck. 1993. Increased transforming growth factor-β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res. 53:4391.
28. Arteaga, C. L., S. D. Hurd, A. R. Winnier, M. D. Johnson, B. M. Fendly, and J. T. Forbes. 1993. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J. Clin. Invest. 92:2569.
29. 2. Cell. Immunol. 123:384.
30. Chen, Q., V. Daniel, D. W. Maher, and P. Hersey. 1994. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated melanoma. Int. J. Cancer 56:755.
31. Awwad, M., and R. J. North. 1988. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. J. Exp. Med. 168:2193.
32. Young, M. R. I., M. A. Wright, J. P. Matthews, I. Malik, and M. Prechel. 1996. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. J. Immunol. 156:1916.
33. Maeda, H., H. Kuwahara, Y. Ichimura, M. Ohtsuki, S. Kurakata, and A. Shiraishi. 1995. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 155:4926.
34. + T cells in the long-term culture of murine tumor-infiltrating lymphocytes: a possible role of transforming growth factor-β. Immunology 89:627.
35. Azumai, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 co-stimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
36. Harding, F. A., J. Mcarthur, J. A. Gross, D. Raulet, and J. P. Allison. 1992. CD28 mediated signaling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607.
37. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
38. Kurosawa, S., M. Harada, G. Matsuzaki, Y. Shinomiya, H. Terao, N. Kobayashi, and K. Nomoto. 1995. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology 85: 338.
39. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whiteman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
40. Nandi, D., J. A. Gross, and J. P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361.
41. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
42. Fox, F. E., H. C. Ford, R. Douglas, S. Cherian, and P. C. Nowell. 1993. Evidence that TGF-β can inhibit human T-lymphocytes proliferation through paracrine and autocrine mechanisms. Cell. Immunol. 150:45.
43. Mule, J. J., S. L. Schwarz, A. B. Robertz, M. B. Sporn, and S. A. Rosenberg. 1988. Transforming growth factor-β inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. 26:95.
44. Ranges, G. E., I. S. Figari, T. Espevik, and J. Palladino. 1987. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by tumor necrosis factor α. J. Exp. Med. 166:991.
45. Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. Jakowlew, M. B. Sporn, and A. S. Fauci. 1986. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855.
46. Ballone, G., M. Aste-Amezaga, G. Trinchieri, and U. Rodeck. 1995. Regulation of NK cell functions by TGF-β1. J. Immunol. 155:1066.
47. Assoian, R. K., B. E. Fluerdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020.
48. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154:4333.
49. + T lymphocytes. Science 268:863.
50. Azuma, E., and J. Kaplan. 1988. Role of lymphokine-aclivated killer (LAK) cells as mediators of veto and natural suppression. J. Immunol. 141:2601.
51. Fast, L. D. 1993. Generation and characterization of IL-2-activated veto cells. J. Immunol. 149:1510.
52. Hambor, J. E., M. C. Weber, M. L. Tykocinski, and D. R. Kaplan. 1990. Regulation of allogeneic responses by expression of CD8 α-chain on stimulator cells. Int. Immunol. 2:879.
53. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115.
54. Nishio, M., J. Spielman, R. K. Lee, D. L. Nelson, and B. R. Podack. 1996. CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis. J. Immunol. 157:4347.
55. + cell lines. Cell. Immunol. 129:478.
56. Strober, S., V. Palathumpat, R. Schwadron, and B. Hertel Wulff. 1987. Cloned natural suppressor cells prevent lethal graft-vs-host disease. J. Immunol. 138:699.